Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

BACKGROUND: Before the targeted therapies era, cytotoxic chemotherapy (CCT) was an option for advanced hepatocellular carcinoma (HCC), even with the lack of supporting evidence. Since the last decade, sorafenib has been established as the first-line therapy. Although new agents are being incorporate...

Descripción completa

Detalles Bibliográficos
Autores principales: da Fonseca, Leonardo Gomes, Marta, Guilherme Nader, Braghiroli, Maria Ignez Freitas Melro, Chagas, Aline Lopes, Carrilho, Flair Jose, Hoff, Paulo Marcelo, Sabbaga, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293528/
https://www.ncbi.nlm.nih.gov/pubmed/30545331
http://dx.doi.org/10.1186/s12885-018-5173-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293528/
https://www.ncbi.nlm.nih.gov/pubmed/30545331
http://dx.doi.org/10.1186/s12885-018-5173-0

Ejemplares similares